ATE300951T1 - Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine - Google Patents

Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine

Info

Publication number
ATE300951T1
ATE300951T1 AT02729699T AT02729699T ATE300951T1 AT E300951 T1 ATE300951 T1 AT E300951T1 AT 02729699 T AT02729699 T AT 02729699T AT 02729699 T AT02729699 T AT 02729699T AT E300951 T1 ATE300951 T1 AT E300951T1
Authority
AT
Austria
Prior art keywords
cell death
prevention
segments
tissue
neurofilament proteins
Prior art date
Application number
AT02729699T
Other languages
English (en)
Inventor
Paul A Averback
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nymox Corp filed Critical Nymox Corp
Application granted granted Critical
Publication of ATE300951T1 publication Critical patent/ATE300951T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02729699T 2001-05-16 2002-05-16 Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine ATE300951T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29097101P 2001-05-16 2001-05-16
PCT/CA2002/000712 WO2002092115A2 (en) 2001-05-16 2002-05-16 Method of preventing cell death using segments of neural thread proteins

Publications (1)

Publication Number Publication Date
ATE300951T1 true ATE300951T1 (de) 2005-08-15

Family

ID=23118262

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02729699T ATE300951T1 (de) 2001-05-16 2002-05-16 Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine
AT05003125T ATE381342T1 (de) 2001-05-16 2002-05-16 Prävention des zelltodes durch verwendung von segmenten der neurofilamentproteinen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05003125T ATE381342T1 (de) 2001-05-16 2002-05-16 Prävention des zelltodes durch verwendung von segmenten der neurofilamentproteinen

Country Status (12)

Country Link
US (1) US7572450B2 (de)
EP (1) EP1392347B1 (de)
JP (1) JP2004529179A (de)
KR (1) KR20040008177A (de)
CN (1) CN1558770A (de)
AT (2) ATE300951T1 (de)
BR (1) BR0209630A (de)
CA (1) CA2446945A1 (de)
DE (2) DE60205366T2 (de)
DK (1) DK1392347T3 (de)
ES (1) ES2247329T3 (de)
WO (1) WO2002092115A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259232B1 (en) 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
CN1582301A (zh) 2001-05-25 2005-02-16 尼莫克斯股份有限公司 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US7544771B2 (en) * 2005-02-23 2009-06-09 Nymox Corporation Protein and its use in diagnosing Alzheimer's disease
US20160361380A1 (en) * 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US11628202B2 (en) * 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641376B2 (en) 1988-12-21 1993-09-23 General Hospital Corporation, The Method of detecting neurological disease or dysfunction
US5948634A (en) 1988-12-21 1999-09-07 The General Hospital Coporation Neural thread protein gene expression and detection of alzheimer's disease
ATE406444T1 (de) * 1993-04-20 2008-09-15 Gen Hospital Corp Geneexpression der neurofilamentproteine und nachweis der alzheimeschen erkrankung
CN1300779A (zh) 1999-12-22 2001-06-27 上海博德基因开发有限公司 一种新的多肽－人神经元线蛋白17和编码这种多肽的多核苷酸
CN1300778A (zh) 1999-12-22 2001-06-27 上海博德基因开发有限公司 一种新的多肽－人神经元线蛋白15和编码这种多肽的多核苷酸
US7259232B1 (en) * 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
WO2002074323A2 (en) 2001-03-08 2002-09-26 Nymox Pharmaceutical Corporation Using neural thread proteins to treat tumors and other hyperproliferative disorders

Also Published As

Publication number Publication date
KR20040008177A (ko) 2004-01-28
BR0209630A (pt) 2004-03-30
DE60205366T2 (de) 2006-05-24
CN1558770A (zh) 2004-12-29
EP1392347A2 (de) 2004-03-03
WO2002092115A2 (en) 2002-11-21
DK1392347T3 (da) 2005-12-12
DE60224231D1 (de) 2008-01-31
DE60205366D1 (de) 2005-09-08
CA2446945A1 (en) 2002-11-21
JP2004529179A (ja) 2004-09-24
WO2002092115A3 (en) 2003-05-15
HK1060851A1 (en) 2004-08-27
US7572450B2 (en) 2009-08-11
EP1392347B1 (de) 2005-08-03
ATE381342T1 (de) 2008-01-15
US20030004107A1 (en) 2003-01-02
ES2247329T3 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
DE60143520D1 (de) Inhibitoren der histon-deacetylase
BR9903571A (pt) Método para inibição de glicogênio fosforilase humano
ATE300951T1 (de) Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine
DK1233958T3 (da) Hæmmere af histondeacetylase
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
MXPA04002397A (es) Inhibidores de histona deacetilasa.
PL402389A1 (pl) Sposób hamowania aktywnosci kinazy Raf u ludzi lub zwierzat
ATE463490T1 (de) Histondeacetylase-hemmer
BR9916785A (pt) Tratamento de asma com inibidores mek
DE69815090D1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DK0752813T3 (da) Hæmmere af metozoan-parasit-proteaser
ATE554169T1 (de) Smad7-inhibitoren zur behandlung von krankheiten des zns
PT1250340E (pt) Metodos e compostos para inibicao de mrp1
BR0213126A (pt) Compostos heterocìclicos insaturados de 6 membros úteis para inibição seletiva da cascata de coagulação
NO20006478D0 (no) Fremgangsmåter for inhibering av korrosjon ved anvendelse av isomerer av klor-metylbenzotriazol
DK0981549T3 (da) Anvendelse af inhiberende stof til forbedring af regenereringen af neutroner
ATE250030T1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
ES2144513T3 (es) Inhibicion de crecimiento tumoral inducido por traumatismo.
BR0009143A (pt) Mediação inflamatória obtida de atractylodeslancea
SE0400399D0 (sv) Methods and compositions for the treatment or prevention of secondary ischemic injury
ATE378069T1 (de) Verfahren zur vorbeugung von zelltod unter verwendung von antikörpern gegen neural thread proteine
BR0213092A (pt) Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação
BR0214832A (pt) Inibição de tristetraprolina para proteção do coração contra danos cardìacos
ATE290878T1 (de) Inhibierung von invasiver remodulierung
BR9807920A (pt) Processos para tratamento de uma demência em um sujeito e para prevenção de uma demência

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1392347

Country of ref document: EP

REN Ceased due to non-payment of the annual fee